Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers

Clinical trial NCT01292174 · COMPLETED

Trial details

NCT number: NCT01292174
Sponsor: TaiMed Biologics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prevention of Infection With HIV-1

Start date: 2011-02-01
Primary completion: 2012-09-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.